Senores Pharmaceuticals Clarifies Stock Volume Movement to Exchanges
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 5:29 pm
Senores Pharmaceuticals Clarifies Stock Volume Movement to Exchanges Senores Pharmaceuticals clarified on 21st Sep'26 regarding recent volume movement in its scrip on the BSE and NSE. The company confirmed compliance with SEBI (LODR) Regulations, stating that it has promptly reported all material information affecting operations or performance. Management confirmed there is no undisclosed or price-sensitive information, impending announcement, or corporate action requiring disclosure that could have triggered the volume fluctuation. The company reiterated its commitment to promptly notify exchanges of any future material developments.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
